Relevant bibliographies by topics / Chronic virus hepatites

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Chronic virus hepatites'

Author: Grafiati
Published: 28 May 2022
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Chronic virus hepatites.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Chronic virus hepatites"

1

Galyan, Ye V., Ye B. Kravets, V. N. Latypova та D. Damdindorj. "Structural features of a pathology and functional condition of a thyroid gland in patients with a chronic virus hepatites В and С". Bulletin of Siberian Medicine 8, № 2 (2009): 96–100. http://dx.doi.org/10.20538/1682-0363-2009-2-96-100.

Full text
Abstract:
Studying a condition thyroid systems according to objective survey, ultrasonic inspection, research thyroid the status at patients with the verified diagnosis a chronic hepatites B and C. 50 patients (29 men and 21 women, in the age of from 18 till 59 years, (middle age (22,3 ± 3,8) year) is lead, average duration of disease (3,4 ± 1,2) year with a chronic hepatites B and C. structure of a pathology of a thyroid gland, clinical current autoimmune pathology on a background of a hepatites is estimated B and C, parameters of a functional condition thyroid systems at the given group of patients ar
APA, Harvard, Vancouver, ISO, and other styles
2

Viana, Daniel Rodrigues, Nathalia Mundoco Veloso, Osvaldo Carvalho Neto, Nicolas Garcia Papacosta, Gabriel Martins Nunes, and Virgílio Ribeiro Guedes. "Hepatite B e C: diagnóstico e tratamento." Revista de Patologia do Tocantins 4, no. 3 (2017): 73. http://dx.doi.org/10.20873/uft.2446-6492.2017v4n3p73.

Full text
Abstract:
INTRODUÇÃO: As hepatites virais são consideradas as principais doenças hepáticas, podendo levar a quadros mais graves, como a cirrose e o carcinoma hepatocelular, tornando-se um importante problema de saúde pública. Tem distribuição global com áreas de altos índices de endemicidade, sobretudo em países asiáticos. Os principais agentes envolvidos são os vírus da hepatite A, B, C, D, E. O vírus da hepatite B e C se destacam nesse meio devido à grande capacidade de cronificação. As formas de transmissão são basicamente através do contato com fluidos corporais infectados, através de transfusões sa
APA, Harvard, Vancouver, ISO, and other styles
3

Enaleeva, D. Sh, and V. Kh Fazylov. "The role of primary care physicians in diagnosis and follow-up of patients with chronic viral hepatites B, C and D." Kazan medical journal 95, no. 3 (2014): 439–45. http://dx.doi.org/10.17816/kmj1532.

Full text
Abstract:
By 01.01.2013 in the Republic of Tatarstan there were 23 970 Hepatitis B Surface Antigen carriers and 4546 patients with active Hepatitis B out of 28 516 registered patients who were infected with Hepatitis B. Our experience shows that not only inactive chronic Hepatitis B Surface Antigen carriers, but also patients with different clinical forms of Hepatitis B might be estimated as Hepatitis B Surface Antigen carriers. The feature of chronic viral hepatitides is a discrepancy between the scarce clinical picture and presence (in 15-30% of cases) of active inflammation in liver tissue. Since 200
APA, Harvard, Vancouver, ISO, and other styles
4

Zhoukova, O. B. "Molecular mechanisms of lymphocyte apoptosis injury in chronic viral infection." Bulletin of Siberian Medicine 5, no. 3 (2006): 19–25. http://dx.doi.org/10.20538/1682-0363-2006-3-19-25.

Full text
Abstract:
Programmed cell death of lymphocytes in patients with chronic infections induced by tick-borne encephalitis, hepatites B and C was investigated. The injury character in realization of lymphocyte apoptosis is shown to depend on molecular features of the infectious agent. Apoptotic death of lymphocytes was elevated after their incubation in vitro with dexamethazone, etopozide and in the environment without serum. Receptor-dependent and mitochondrial paths of apoptotic signal conduction ways are preferably modulated in chronic virus persistence.
APA, Harvard, Vancouver, ISO, and other styles
5

Sklyar, L. Ph, and E. V. Markelova. "TO THE QUESTION ABOUT IMMUNOLOGIES CRITERIAS OF EFFICIENCY OF ANTIVIRUS THERAPY OF A CHRONIC VIRUS HEPATITES C." Medical Immunology (Russia) 8, no. 5-6 (2014): 673. http://dx.doi.org/10.15789/1563-0625-2006-5-6-673-678.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Leite, Alice Gramosa da Silva, Luanna Mota Damasceno, Suzana Coelho Conceição, and Pedro Flávio Costa Motta. "Rapid tests for HIV, syphilis, and chronic hepatitis in a prison population in a prison complex in Salvador (BA), Brazil." Ciência & Saúde Coletiva 27, no. 12 (2022): 4467–74. http://dx.doi.org/10.1590/1413-812320222712.10462022en.

Full text
Abstract:
Abstract This study aimed to quantitatively analyze the results of rapid tests for Human Immunodeficiency Virus (HIV), Syphilis, and Chronic Hepatitis in the prison population in a prison complex in Salvador (BA), Brazil. This cross-sectional study consisted of a sample of men incarcerated from August 2018 to August 2020 submitted to rapid tests. Descriptive statistics and prevalence ratios with respective 95% confidence intervals were employed to analyze data. A total of 6,160 men were studied. Most were black and brown (93.1%) and resided in Salvador (BA), Brazil (65.8%), with predominantly
APA, Harvard, Vancouver, ISO, and other styles
7

ChurbakOVa, Olga V. "estimation of the cellulaR paRt of immunity and its inteRRelation with the cytolytic syndRome at the chRonic viRus hepatites в at childRen". Bulletin of Contemporary Clinical Medicine 6, № 4 (2013): 13–17. http://dx.doi.org/10.20969/vskm.2013.6(4).13-17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Bogomolov, P. O., A. O. Bueverov, M. V. Matsievich, et al. "Epidemiology of hepatitis C in the Moscow Region: data from the Moscow Regional Registry and screening for HCV antibodies." Almanac of Clinical Medicine 44, no. 6 (2016): 689–96. http://dx.doi.org/10.18786/2072-0505-2016-44-6-689-696.

Full text
Abstract:
Background: Epidemiological characteristics of chronic hepatitis C virus (HCV) infection presented in the literature are not representative for the real situation with its incidence and prevalence in the Russian Federation. In the Moscow Region, which is the second largest population in the Russian Federation (7.2 million people), the Moscow Regional Registry of patients with hepatic disorders has been continuously maintained since 2010, as well as screening programs for anti-HCV positive individuals. Analysis of this data allows for generalization of the results obtain to the general populati
APA, Harvard, Vancouver, ISO, and other styles
9

Austin, Publishing Group. "Tackling the Burden of Viral Hepatitis in India: A Call for Collaborative Efforts." Journal of Hepatitis Research 8, no. 1 (2023): 1049. https://doi.org/10.26420/jhepatres.2023.1049.

Full text
Abstract:
Viral hepatitis is defined as a widespread infectious disease involving the inflammation of liver caused by hepatitis virus A, B, C, D and E. The majority of deaths linked to viral hepatitis are caused by HBV, HCV, and HDV, which are transmitted parenterally and induce chronic hepatitis with distant sequelae like liver cirrhosis and hepatocellular cancer [1]. According to WHO latest estimates, viral hepatitis is now acknowledged as a serious public health problem in India with over 40 million people chronically infected with HBV and six to twelve million people with HCV. In a study dated in 20
APA, Harvard, Vancouver, ISO, and other styles
10

Babar, Javaid, Amir Gillani Syed, Ali Siddiqui Mustafa, et al. "Correlation of Sonographic Appearance of Chronic Liver Disease with Serological Findings of Hepatitis B and C in Multan City." Journal of Health and Medical Sciences 2, no. 2 (2019): 202–13. https://doi.org/10.31014/aior.1994.02.02.38.

Full text
Abstract:
Liver cirrhosis is the irrecoverable disease of the liver, finally it causes necrosis of liver cells, as a result, change normal cells into an abnormal knot as well as structural abnormalities occur. It caused by many of reason, but here we discussed only by the hepatitis b virus and hepatitis b virus. The hazard of liver cirrhosis increased day by day. Recently liver cirrhosis prevalence of Pakistan was 13.5%. Sonography can easily diagnose the liver cirrhosis caused by hepatitis b and c virus. Objective: The object of this study to examine the analyses of ultra-sonographic diagnosis of liver
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Chronic virus hepatites"

1

Silva, Edvaldo Ferreira da. "Prevalência de marcadores sorológicos das hepatites A e B em pacientes com hepatite C crônica atendidos no ambulatório de hepatites do serviço de Gastroenterologia Clínica do Hospital das Clínicas da Faculdade de Medicina da Universidade." Universidade de São Paulo, 2014. http://www.teses.usp.br/teses/disponiveis/5/5168/tde-04022015-153903/.

Full text
Abstract:
Introdução: Pacientes com infecção crônica pelo VHC e superinfecção pelo vírus da hepatite A (VHA) ou o vírus da hepatite B (VHB), têm maior morbi-mortalidade quando comparados com pacientes que apresentam infecção aguda somente pelo VHA ou VHB. A mortalidade associada à hepatite A aguda pode estar particularmente elevada em pacientes com pré-existência de hepatite crônica causada pelo VHC. Por esta razão, a imunização ativa com vacinas contra o VHA e o VHB vem a ser obrigatória nesta população, e consequentemente esta sorologia deve ser determinada. Objetivos: O objetivo deste trabalho foi a
APA, Harvard, Vancouver, ISO, and other styles
2

Кулеш, Лариса Петрівна, Лариса Петровна Кулеш, Larysa Petrivna Kulesh та ін. "Досвід застосування біопсії печінки: клініко-лабораторні паралелі". Thesis, Сумський державний університет, 2014. http://essuir.sumdu.edu.ua/handle/123456789/37928.

Full text
Abstract:
З’ясування характеру і стадії морфологічних змін у печінці при хронічних вірусних гепатитах лишається досить актуальним для встановлення розгорнутого діагнозу, виключення інших чинників ураження органу (стеатозу, автоімунних факторів, порушень метаболiзму), визначення ступеня альтерації, фіброзу та невідкладності призначення противірусної терапії. Не зважаючи на те, що «золотим стандартом» у цій діагностиці була і лишається біопсія, останнім часом з’явилися інші методики (еластометрія, фібротести), які за рахунок неінвазивності мають певний інтерес для клініцистів і пацієнтів.
APA, Harvard, Vancouver, ISO, and other styles
3

駱淑芳 and Suk-fong Anna Lok. "Replication of hepatitis B virus in Chinese patients with chronic hepatitis B virus infection." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1990. http://hub.hku.hk/bib/B31981392.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Williams, Stephen John. "Chronic hepatitis B virus infection : prevention and treatment." Thesis, The University of Sydney, 1989. https://hdl.handle.net/2123/26390.

Full text
Abstract:
Hepatitis B virus (HBV) infection is an increasing public health problem in Australia particularly in certain 'high-risk' subgroups of the population. In order to establish cost-effective screening and vaccination programs directed towards the control and possible eradication of HBV infection, accurate information is needed about the modes of spread and the numbers of "at risk" individuals in particular community subgroups. In addition, treatment strategies must be developed for established HBV carriers since at least 35% of such individuals will die directly related to complications of the di
APA, Harvard, Vancouver, ISO, and other styles
5

Christie, John Michael Landale. "Viral persistence in hepatitis C virus infection." Thesis, University of Southampton, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.268465.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Albuquerque, Marina Brandão Braz. "APLICAÇÃO DOS MÉTODOS APRI E FIB4 PARA O ESTADIAMENTO DE FIBROSE HEPÁTICA PRÉ E PÓS TRATAMENTO EM PACIENTES COM DIAGNÓSTICO DE HEPATITE C." Pontifícia Universidade Católica de Goiás, 2018. http://tede2.pucgoias.edu.br:8080/handle/tede/3979.

Full text
Abstract:
Submitted by admin tede (tede@pucgoias.edu.br) on 2018-05-28T19:39:54Z No. of bitstreams: 1 Marina Brandão Braz Albuquerque.pdf: 605500 bytes, checksum: 1405379cffb1283fb04eb721d76cc92a (MD5)<br>Made available in DSpace on 2018-05-28T19:39:54Z (GMT). No. of bitstreams: 1 Marina Brandão Braz Albuquerque.pdf: 605500 bytes, checksum: 1405379cffb1283fb04eb721d76cc92a (MD5) Previous issue date: 2018-03-27<br>The use of hepatic biopsy to assess the stay of the level of fibrosis continues to be gold standard but may present some risks during the procedure and high cost. Given that the WHO suggest
APA, Harvard, Vancouver, ISO, and other styles
7

Rodrigues, João Paulo Vilela. "Efetividade e segurança dos inibidores da protease de primeira geração indicados ao tratamento de pacientes cronicamente infectados pelo genótipo 1 do HCV." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2017. http://hdl.handle.net/10183/170513.

Full text
Abstract:
Aprovados para o tratamento da hepatite C crônica (HCC) em 2011, os inibidores da protease (IPs) de primeira geração telaprevir (TVR) e boceprevir (BOC) representaram o início de uma nova era caracterizada pelo desenvolvimento de fármacos de ação direta contra o vírus da hepatite C (HCV). Os principais objetivos do presente trabalho foram descrever a efetividade e as incidências de eventos adversos ao uso de BOC ou TVR em esquema triplos com interferon peguilado (Peg-INF) e ribavirina (RBV), verificar a associação de fatores do hospedeiro e de fatores virais com a resposta virológica sustentad
APA, Harvard, Vancouver, ISO, and other styles
8

Ferreira, Ariana Carolina. "Pesquisa de marcadores sorológicos e moleculares da infecção pelo Vírus da Hepatite E (HEV) em indivíduos portadores do Vírus da Imunodeficiência Humana (HIV)." Universidade de São Paulo, 2016. http://www.teses.usp.br/teses/disponiveis/5/5168/tde-30062016-115114/.

Full text
Abstract:
A infecção pelo HEV é reconhecida como um considerável problema de saúde pública em diversas regiões do mundo. Embora caracterizada como uma infecção benigna com um curso evolutivo autolimitado, recentes estudos têm mostrado sua evolução para cronicidade em indivíduos imunocomprometidos. Além disso, tem sido verificado que nesses indivíduos a infecção crônica pelo HEV pode evoluir para fibrose hepática progressiva, culminando com o desenvolvimento de cirrose. Não existem dados acerca da prevalência da infecção pelo HEV em pacientes infectados pelo HIV no Brasil, onde a circulação deste vírus t
APA, Harvard, Vancouver, ISO, and other styles
9

Stoop, Jeroen nicolaas. "Regulatory T cells in chronic hepatitis B virus infection." [S.l.] : Rotterdam : [The Author] ; Erasmus University [Host], 2007. http://hdl.handle.net/1765/11766.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Lai, Ching-lung. "Chronic hepatitis B-related liver diseases in the Chinese." Hong Kong : University of Hong Kong, 1993. http://sunzi.lib.hku.hk/hkuto/record.jsp?B13814060.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Chronic virus hepatites"

1

Shiffman, Mitchell L., ed. Chronic Hepatitis C Virus. Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-1192-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

1944-, Gerlich W. H., ed. Research in chronic viral hepatitis. Springer-Verlag, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Green, William Finley. The first year-- hepatitis B: An essential guide for the newly diagnosed. Marlowe & Co., 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Husereau, Donald Robert. Interferon-based therapies for chronic hepatitis C virus infection: An assessment of clinical outcomes. Canadian Coordinating Office for Health Technology Assessment, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bruce, Brady, and Canadian Agency for Drugs and Technologies in Health., eds. Pegylated interferon combined with ribavirin for chronic hepatitis c virus infection: An economic evaluation. Canadian Agency for Drugs and Technologies in Health, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Lindh, Gudrun. Chronic hepatitis B: Impact of hepatitis D virus superinfection and the hepatitis B e-system on histological outcome, and correlation of the hepatitis B e-system to HBV-DNA in serum. Distributed by the Almqvist & Wiksell Periodical Co., 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

institutet, Karolinska, ed. Chronic hepatitis B: Impact of hepatitis D virus superinfection and the hepatitis B e-system on histological outcome, and correlation of the hepatitis B e-system to HBV-DNA in serum. Distributed by Almqvist & Wiksell Periodical Co., 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Chronic Hepatitis B. W.B. Saunders Company, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kourtis, Athena P., Shruti Chandramouli, Gonzague Jourdain, and Marc Bulterys. Hepatitis B Virus. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190604813.003.0004.

Full text
Abstract:
Hepatitis B virus (HBV) is the most common cause of chronic viral hepatitis and hepatocellular carcinoma in the world. Worldwide, more than 250 million people are chronically infected with HBV, causing nearly 780,000 deaths each year, and mother-to-child transmission (MTCT) accounts for more than one-third of chronic HBV infections. Universal vaccination in neonates is the most effective strategy for eliminating infections worldwide. Maternal antiviral treatment during the antepartum/postpartum period for mothers with high HBV viral loads is effective in preventing HBV MTCT. Full immunization
APA, Harvard, Vancouver, ISO, and other styles
10

Honegger, Jonathan R. Hepatitis C Virus. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190604813.003.0005.

Full text
Abstract:
An estimated 185 million individuals have been infected with hepatitis C virus (HCV) worldwide. Although often clinically silent for decades, chronic HCV infection predisposes to late-onset complications, including liver cirrhosis and hepatocellular carcinoma. Mother-to-child transmission (MTCT) of HCV affects approximately 5% of children born to viremic mothers and is the primary route of HCV infection in young children. While some vertically acquired HCV infections are resolved during the first years of life, many persist indefinitely. Chronically infected children tend to be asymptomatic an
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Chronic virus hepatites"

1

Davis, Gary L. "Epidemiology of Chronic HCV." In Chronic Hepatitis C Virus. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-1192-5_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kemp, William, and Stuart K. Roberts. "Treatment with Interferon and Ribavirin." In Chronic Hepatitis C Virus. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-1192-5_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Charles, Edgar D., and Ira M. Jacobson. "Immune Modulators and Other Agents." In Chronic Hepatitis C Virus. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-1192-5_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Pawlotsky, Jean-Michel. "Measuring HCV RNA and Assessing Virologic Response." In Chronic Hepatitis C Virus. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-1192-5_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Shiffman, Mitchell L. "Response-Guided Therapy." In Chronic Hepatitis C Virus. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-1192-5_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Cooper, Curtis. "Managing the Side Effects of Therapy." In Chronic Hepatitis C Virus. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-1192-5_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Jazwinski, Alison B., and Andrew J. Muir. "The Genetics of Virologic Response." In Chronic Hepatitis C Virus. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-1192-5_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Malik, Raza, and Nezam H. Afdhal. "Maintenance Therapy with Peginterferon." In Chronic Hepatitis C Virus. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-1192-5_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kronenberger, B., and S. Zeuzem. "Antiviral Targets in HCV." In Chronic Hepatitis C Virus. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-1192-5_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Geretti, Anna Maria, and Geoff Dusheiko. "Mutations and the Development of Anti-viral Resistance." In Chronic Hepatitis C Virus. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-1192-5_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Chronic virus hepatites"

1

"A CROSS-SECTIONAL STUDY OF KNOWLEDGE, ATTITUDES AND PRACTICE ABOUT HEPATITIS IN A SUB-URBAN COMMUNITY IN SOUTH-WESTERN NIGERIA." In International Conference on Public Health and Humanitarian Action. International Federation of Medical Students' Associations - Jordan, 2022. http://dx.doi.org/10.56950/jhhi8301.

Full text
Abstract:
Background: The hepatitis B virus (HBV) is a common infection that causes viral hepatitis B, which accounts for the world's most common cause of acute and chronic liver disorders. The WHO estimates 257 million people, or 3.5% of the world's population, had chronic HBV infection in 2015. July 28 every year, the world comes together under "World Hepatitis Day" (WHD) to raise awareness of the burden of viral hepatitis around the world. Objective: This study was conducted on WHD 2021 to evaluate the knowledge, attitude and practice toward hepatitis in an urban community in south-western Nigeria. M
APA, Harvard, Vancouver, ISO, and other styles
2

Hussain, Hiba T. H., Arwa Mujahid Abdullah Al-Shuwaikh, and Abbas M. Ahmed. "Hepatitis type B virus genotypes in chronic Hepatitis B patients (CHBP)." In 2ND INTERNATIONAL CONFERENCE OF MATHEMATICS, APPLIED SCIENCES, INFORMATION AND COMMUNICATION TECHNOLOGY. AIP Publishing, 2023. http://dx.doi.org/10.1063/5.0162114.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Long, Changjiang, Huan Qi, and Wan Peng. "System Dynamics of Chronic Hepatitis B - Modeling the Virus and Immune System of Chronic Hepatitis B." In 2010 2nd International Workshop on Intelligent Systems and Applications (ISA). IEEE, 2010. http://dx.doi.org/10.1109/iwisa.2010.5473320.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Rakić, Violeta, and Jelena Simić. "Analysis of trends in the incidence of acute hepatitis B virus infection in the Republic of Serbia in the period from 2003 to 2022." In Proceedings of the International Congress Public Health - Achievements and Challenges. Institute of Public Health of Serbia "Dr Milan Jovanović Batut", 2024. http://dx.doi.org/10.5937/batutphco24128r.

Full text
Abstract:
Background: Hepatitis B virus (HBV) is a common worldwide blood-borne pathogen. WHO estimates that 254 million people were living with chronic hepatitis B infection in 2022, with 1.2 million new infections each year. In 2022, hepatitis B resulted in an estimated 1.1 million deaths, mostly from cirrhosis and hepatocellular carcinoma (primary liver cancer). Hepatitis B can be prevented by vaccines that are safe, available and effective. Chronic hepatitis B can progress to an inactive carrier state, and then, in some patients, give rise to cirrhosis and cancer of the liver, leading to death. An H
APA, Harvard, Vancouver, ISO, and other styles
5

Lemos, Andreza, Camilla Ribeiro, Jakeline Barbosa, et al. "Hepatitis E virus prevalence among chronic kdney disease hemodialysis-dependent patients." In IV International Symposium on Immunobiologicals & VII Seminário Anual Científico e Tecnológico. Instituto de Tecnologia em Imunobiológicos, 2019. http://dx.doi.org/10.35259/isi.sact.2019_32756.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

"PS-040 - RELEVANCIA DE LA PATOLOGÍA DUAL EN LA INFECCIÓN DEL VHC EN PACIENTES INGRESADOS EN LA UNIDAD DE HOSPITALIZACIÓN BREVE DE PSIQUIATRÍA DE SALAMANCA." In 24 CONGRESO DE LA SOCIEDAD ESPAÑOLA DE PATOLOGÍA DUAL. SEPD, 2022. http://dx.doi.org/10.17579/abstractbooksepd2022.ps040.

Full text
Abstract:
La prevalencia de hepatitis C es claramente superior en pacientes con adicciones y se ha demostrado la relevancia de la presencia de patología dual en unidades de subagudos de Psiquiatría. Existen pocos datos de su prevalencia y relevancia en Unidades de Hospitalización Breve. Se estudia una muestra de 1841 ingresos realizados entre el enero del 2017 y octubre del 2021. Un 40% eran reingresos de pacientes por lo que se incluyen 1096 pacientes distintos (52,1% eran mujeres), edad media de edad 49,62 (DT=16,27). 340 sujetos (31,3%) padecían Trastornos psicóticos, 180 depresivos (17%), 105 Trasto
APA, Harvard, Vancouver, ISO, and other styles
7

Hundur Hiyari, Madžida, Nejra Merdović, Faruk Bećirović, Emina Mrđanović, and Adna Softić. "Liver Disease Classification Using Machine Learning." In Artificial Intelligence in Industry 4.0: The future that comes true. Academy of Sciences and Arts of Bosnia and Herzegovina, 2024. http://dx.doi.org/10.5644/pi2024.215.16.

Full text
Abstract:
Hepatitis C virus (HCV) is a significant cause of liver-related diseases including acute and chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Despite the availability of advanced treatments, underdiagnosis remains a critical challenge, particularly in resource-limited settings. This study explores the application of machine learning algorithms, specifically the K-Nearest Neighbors (KNN) method, to enhance the diagnosis of HCV by classifying patients into healthy, potentially diseased, and diseased categories based on liver function test results. Using a biomedical dataset of 615 pat
APA, Harvard, Vancouver, ISO, and other styles
8

Velkov, S., JJ Ott, U. Protzer, and T. Michler. "Estimation of the genotype distribution within global chronic hepatitis B virus infections." In 35. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0038-1677297.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wang, Yue-lan, Bing-chen Huang, and Liu-da Ni. "Effects of He-Ne laser acupuncture-point irradiation on serology hepatitis virus markers in chronic hepatitis B." In International Conference on Photodynamic Therapy and Laser Medicine, edited by Junheng Li. SPIE, 1993. http://dx.doi.org/10.1117/12.136954.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kurniati, Nurul. "Analysis of Factors and Management of Hepatitis B Virus Screening in Mothers and Infants: A Scoping Review." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.03.67.

Full text
Abstract:
ABSTRACT Background: The importance of screening for HBV infection is to identify the risk of perinatal transmission from infected mothers. People infected with HBV during infancy or childhood are more likely to suffer chronic infection to cirrhosis of the liver and liver cancer. Early detection and prompt treatment are essential for HBV infection. This study aimed to review the factors and management of hepatitis B virus screening in mothers and infants. Subjects and Method: A scoping review method was conducted in eight stages including (1) Identification of study problems; (2) Determining p
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Chronic virus hepatites"

1

Talal, Andrew, Marianthi Markatou, Ponni Perumalswami, et al. Facilitated Telemedicine for Underserved Populations: Management of Chronic Hepatitis C Virus Infection. The TEAM-C Study. Patient-Centered Outcomes Research Institute (PCORI), 2025. https://doi.org/10.25302/04.2025.ihs.150731640.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Evon, Donna, Jipcy Amador, Paul Stewart, et al. Changes in Health for Patients Who Complete Treatment for Chronic Hepatitis C Virus -- The PROP up TARGET Study. Patient-Centered Outcomes Research Institute® (PCORI), 2020. http://dx.doi.org/10.25302/06.2020.cer.140820660.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Tangkijvanith, Pisit. Prevalence and Clinical Significance of Hepatitis B Viral Genotypes and Mutations. Faculty of Medicine, Chulalongkorn University, 2006. https://doi.org/10.58837/chula.res.2006.24.

Full text
Abstract:
Hepatitis B virus (HBV) infection is a major public health problem, with more than 400 million HBV carriers estimated worldwide. Chronic HBV infection is associated with a diverse clinical spectrum of liver damage ranging from asymptomatic carrier status, chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC). There have been increasing lines of evidence to indicate influences of HBV genotypes and mutations on the outcome of liver disease, particularly the development of HCC. The project is aimed to study the prevalence and clinical significance of genotypes and mutations in Precore/
APA, Harvard, Vancouver, ISO, and other styles
4

Xu, Yan, Yuyang Zhao, Yong Wang, et al. Concurrent hepatic steatosis increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B or C virus infection: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.7.0099.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hajarizadeh, Behzad, Jennifer MacLachlan, Benjamin Cowie, and Gregory J. Dore. Population-level interventions to improve the health outcomes of people living with hepatitis B: an Evidence Check brokered by the Sax Institute for the NSW Ministry of Health, 2022. The Sax Institute, 2022. http://dx.doi.org/10.57022/pxwj3682.

Full text
Abstract:
Background An estimated 292 million people are living with chronic hepatitis B virus (HBV) infection globally, including 223,000 people in Australia. HBV diagnosis and linkage of people living with HBV to clinical care is suboptimal in Australia, with 27% of people living with HBV undiagnosed and 77% not receiving regular HBV clinical care. This systematic review aimed to characterize population-level interventions implemented to enhance all components of HBV care cascade and analyse the effectiveness of interventions. Review questions Question 1: What population-level interventions, programs
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Chronic virus hepatites' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography